Sanders Capital’s GSK GSK Stock Holding History

Sanders Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-26,880	Closed	-$1.5M	–	57
2014 Q3	$1.54M	Hold	26,880	–	–	0.02%	48
2014 Q2	$1.8M	Buy	26,880 +24,640	+1,100%	+$1.67M	0.02%	49
2014 Q1	$150K	Hold	2,240	–	–	﹤0.01%	55
2013 Q4	$149K	Hold	2,240	–	–	﹤0.01%	55
2013 Q3	$140K	Hold	2,240	–	–	﹤0.01%	55
2013 Q2	$140K	Buy	+2,240	New	+$142K	﹤0.01%	54

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Sanders Capital's GSK Position: Q4 2014 in Review

Sanders Capital sold out of GSK (GSK) in Q4 2014, closing a stake of 26,880 shares — an estimated $1.5M sold.

Sanders Capital first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $1.8M in Q2 2014. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

Sanders Capital reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
Sanders Capital sold 26,880 GSK shares in Q4 2014, an estimated $1.5M.
Sanders Capital first reported a position in GSK in Q2 2013 and held it in 6 quarters.
Sanders Capital's GSK position peaked at $1.8M in Q2 2014.
729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Sanders Capital's 13F filing for Q4 2014, filed 3 Feb 2015.